Validity Test of Wearable Continuous Blood Pressure Measuring System
NCT ID: NCT04261062
Last Updated: 2020-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
220 participants
OBSERVATIONAL
2020-05-07
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Overview of Research Design This research is simply to obtain and store the data: 1) invasive arterial blood pressure measured with a patient monitor from one wrist, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device from the other wrist.
3. Medical Device for Clinical Trial Patient monitor (IntelliVue MX700, Philips, NED) and wearable blood pressure measuring device
4. Target Recruiting Number of Participants Considering the expected patient number in intensive care and 10% dropout rate during the research period, the target recurring number of participants is 220.
5. Criteria of Participant Inclusion
1. Adult patient in surgical intensive care of Severance Hospital
2. Voluntarily agreed to participate the research and not included to the exclusion criteria
6. Criteria of Participant Exclusion
1. Patient with occlusive peripheral arterial disease
2. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
3. Patient administered high-dose of pressor agent over 15 mcg/min
4. Patient who is not available for measurement of invasive arterial blood pressure
5. Patient who is not available to wear an wearable device on the wrist
6. Pregnant woman, minor
7. Evaluation Parameter
1. Systolic and diastolic blood pressure, which extracted in mmHg unit from the continuous blood pressure output of patient monitor.
2. Blood pressure, which estimated by the signal analysis of multi-wavelength photoplethysmography and pressure signal measured with the wearable device.
8. Data Analysis and Statistical Methods
1. From the multi-wavelength photoplethysmography and multi-channel pressure signal measured, continuous blood pressure will be estimated through the hemodynamic model and machine learning model.
2. For the machine learning model, the data obtained will be divided into the training data and evaluation data, with the ratio of 80% and 20%.
3. In order to evaluate the accuracy of the estimated blood pressure, the invasive arterial blood pressure will be considered as the reference blood pressure. Between the estimated blood pressure and the reference blood pressure, the correlation and root mean square error (RMSE) will be calculated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy of Non-invasive Non-oscillometric Blood Pressure Wristband
NCT03629535
Automatic and Conventional Methods of Hypertensive Patients Monitoring
NCT06929728
Perioperative Blood Pressures and Chronic Hypertension
NCT02136810
Experimental Validation of the Long-term Accuracy of Blood Pressure Measurement Using a Smartwatch
NCT06098092
A Novel Mobile Phone Application ( OptiBP) for Blood Pressure Monitoring
NCT04262323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Explain the research purpose and details, and then have the participant sign the consent form.
3. Before starting the measurement, gather the participant's information such as age, length, and weight.
4. Measure noninvasive blood pressure in both arms. Compared to the blood pressure in the arm where inserted a catheter, confirm if difference of systolic or diastolic blood pressure in the other side of arm is not more than 10%.
5. Wear the wearable device on the opposite wrist from the catheter-inserted.
6. For 10 minutes, simultaneously obtain the data: 1) invasive arterial blood pressure measured with a patient monitor, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device.
7. For accuracy of data acquisition, repeat twice the procedure 5-7 by performing it in the morning and in the afternoon with the 5 hours interval.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subject
Patients in surgical intensive unit
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
3. Patient administered high-dose of pressor agent over 15 mcg/min
4. Patient who is not available for measurement of invasive arterial blood pressure
5. Patient who is not available to wear an wearable device on the wrist
6. Pregnant woman, minor
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yonsei University College of Medicine, Department of Anesthesiology and Pain Medicine
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hughes DJ, Babbs CF, Geddes LA, Bourland JD. Measurements of Young's modulus of elasticity of the canine aorta with ultrasound. Ultrason Imaging. 1979 Oct;1(4):356-67. doi: 10.1177/016173467900100406. No abstract available.
Liu J, Yan BP, Dai WX, Ding XR, Zhang YT, Zhao N. Multi-wavelength photoplethysmography method for skin arterial pulse extraction. Biomed Opt Express. 2016 Sep 27;7(10):4313-4326. doi: 10.1364/BOE.7.004313. eCollection 2016 Oct 1.
Guanqun Zhang, Cottrell AC, Henry IC, McCombie DB. Assessment of pre-ejection period in ambulatory subjects using seismocardiogram in a wearable blood pressure monitor. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:3386-3389. doi: 10.1109/EMBC.2016.7591454.
Corino VD, Lombardi F, Mainardi LT. Blood pressure variability in patients with atrial fibrillation. Auton Neurosci. 2014 Oct;185:129-33. doi: 10.1016/j.autneu.2014.08.002. Epub 2014 Aug 17.
Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology. 2005 Aug;103(2):419-28; quiz 449-5. doi: 10.1097/00000542-200508000-00026.
Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-2019-0080
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.